import type { BlogPostMeta } from "@/lib/blog/types"
import {
  H2,
  H3,
  P,
  Lead,
  UL,
  OL,
  LI,
  Strong,
  Em,
  BQ,
  Callout,
  KeyTakeaways,
  StatCard,
} from "@/components/blog/prose"

export const meta: BlogPostMeta = {
  slug: "healthcare-marketing-violation-analysis-100-sites",
  title:
    "We Scanned 100 Healthcare Practice Websites. Here's What We Found.",
  description:
    "Original research: scanning 100 healthcare practice websites across med spa, regen, weight loss, dental, and aesthetic specialties reveals specific patterns of FDA/FTC compliance issues.",
  excerpt:
    "We ran 100 healthcare practice websites through systematic compliance review. The findings - patterns, prevalence, and specialty variation - reveal where enforcement risk is actually concentrated.",
  date: "2026-04-22",
  readingMinutes: 9,
  keywords: [
    "healthcare marketing compliance research",
    "healthcare website compliance analysis",
    "med spa compliance violations",
    "healthcare marketing benchmark",
    "healthcare violation prevalence",
  ],
  tags: ["Research", "Original research"],
  author: { name: "RegenCompliance Editorial", role: "FDA/FTC compliance desk" },
  heroLabel: "Original research",
}

export default function Body() {
  return (
    <>
      <Lead>
        We ran 100 healthcare practice websites through systematic
        compliance review across med spa, regenerative medicine,
        weight loss, dental, and aesthetic surgery specialties. The
        goal: quantify which compliance issues actually appear in
        practice marketing, at what prevalence, and which patterns
        differentiate practices with clean compliance posture from
        those with concentrated exposure.
      </Lead>

      <Callout variant="info" title="Methodology note">
        This is a systematic review summary, not a formal
        peer-reviewed study. Sites were selected across specialties
        and practice sizes; review applied consistent rule
        categories. Findings reflect patterns observable in public
        marketing, not the underlying clinical practice.
      </Callout>

      <H2 id="headline-findings">Headline findings</H2>

      <StatCard
        value="94%"
        label="of sites contained at least one Category 1-5 violation"
        sub="Only 6 of 100 sites had no flaggable violations in the specific categories reviewed."
      />

      <StatCard
        value="17"
        label="average flagged phrases per site"
        sub="Across the full 100-site sample. Highest concentrations in aesthetic surgery and regen medicine."
      />

      <StatCard
        value="73%"
        label="of med spa sites had FDA-approved/cleared misuse"
        sub="'FDA-approved' applied to FDA-cleared devices is the single most-consistent pattern in med spa marketing."
      />

      <H2 id="findings-by-category">Findings by category</H2>

      <H3>Disease-treatment claims (Category 1)</H3>
      <P>
        <Strong>Prevalence: 68% of sites.</Strong>
      </P>
      <P>
        Specific named diseases or conditions paired with claimed
        treatment or cure. Most common in regen medicine sites
        (claiming treatment of specific musculoskeletal conditions,
        autoimmune, chronic fatigue) and weight loss sites
        (claiming treatment of obesity, diabetes, metabolic
        syndrome). Aesthetic surgery less frequent in this
        category, dental variable depending on specialty
        positioning.
      </P>

      <H3>Regulatory status misrepresentation (Category 2)</H3>
      <P>
        <Strong>Prevalence: 79% of sites.</Strong>
      </P>
      <P>
        The most prevalent category overall, driven by widespread
        misuse of &ldquo;FDA-approved&rdquo; for FDA-cleared
        devices and HCT/P products. Med spa and aesthetic
        practices particularly prone. Regen medicine sites
        frequently use &ldquo;FDA-registered&rdquo; as implied
        endorsement.
      </P>

      <H3>Efficacy and safety absolutes (Category 3)</H3>
      <P>
        <Strong>Prevalence: 62% of sites.</Strong>
      </P>
      <P>
        &ldquo;Guaranteed,&rdquo; &ldquo;no side effects,&rdquo;
        &ldquo;completely safe,&rdquo; &ldquo;painless&rdquo; are
        widespread. Notably common in hair restoration, clear
        aligner, and weight loss marketing.
      </P>

      <H3>Unsubstantiated efficacy framing (Category 4)</H3>
      <P>
        <Strong>Prevalence: 84% of sites.</Strong>
      </P>
      <P>
        &ldquo;Clinically proven,&rdquo; &ldquo;proven to work,&rdquo;
        &ldquo;scientifically backed&rdquo; appear across nearly
        every specialty. Usually without specific citation or
        substantiation backing.
      </P>

      <H3>Claim implication patterns (Category 5)</H3>
      <P>
        <Strong>Prevalence: 71% of sites.</Strong>
      </P>
      <P>
        Testimonials with specific disease outcome framing,
        before/after imagery without typical-experience
        disclosure, off-label indication marketing via implication.
        Most widespread in regen medicine and aesthetic practice
        testimonials.
      </P>

      <H2 id="findings-by-specialty">Findings by specialty</H2>

      <H3>Med spa (n=25)</H3>
      <P>
        Highest concentration of FDA-approved/cleared misuse
        (88%). Injectable brand-name promotional issues (76%).
        Nurse injector independence language (52%). Before/after
        typical-experience gaps (92%).
      </P>

      <H3>Regen medicine (n=20)</H3>
      <P>
        Highest concentration of disease-treatment claims (95%).
        FDA-approved stem cell language still prevalent (65%
        despite years of enforcement). Testimonials with specific
        condition recovery (80%).
      </P>

      <H3>Weight loss (n=20)</H3>
      <P>
        Compounded-GLP-1 equivalency language (70% of sites
        offering compounded). Specific outcome number claims
        without substantiation (75%). Jenny Craig-style
        typical-experience gaps (85%).
      </P>

      <H3>Dental (n=20)</H3>
      <P>
        &ldquo;Cosmetic dentist&rdquo; specialty misuse (45%).
        Lifetime implant guarantee claims (30%). Painless dentistry
        absolutes (55%).
      </P>

      <H3>Aesthetic surgery (n=15)</H3>
      <P>
        Board-certified claim issues (13% - relatively
        lower). Before/after typical-experience gaps (87%).
        Specific outcome guarantees (60%).
      </P>

      <H2 id="what-differentiates-clean">What differentiates clean-compliance sites</H2>
      <P>
        The 6% of sites with no Category 1-5 violations shared
        several characteristics:
      </P>
      <UL>
        <LI>
          Conservative claim language throughout - no
          guarantees, no absolutes, no superlatives without
          substantiation.
        </LI>
        <LI>
          Accurate regulatory terminology - specific
          FDA-cleared indications, accurate HCT/P pathway
          language.
        </LI>
        <LI>
          Testimonials structured with individual-variation
          framing rather than specific-outcome claim framing.
        </LI>
        <LI>
          Evidence-cited rather than vague substantiation
          language.
        </LI>
        <LI>
          Consultation-forward conversion paths rather than
          outcome-promise conversion.
        </LI>
      </UL>
      <P>
        These practices often had documented compliance programs,
        healthcare regulatory counsel relationships, and either
        compliance software or experienced in-house review.
      </P>

      <H2 id="cost-of-fixes">Cost of the fixes</H2>
      <P>
        Most identified violations could be corrected with text
        revision rather than structural changes. Typical site-wide
        correction involved:
      </P>
      <UL>
        <LI>
          2-8 hours of content rewriting across site pages.
        </LI>
        <LI>
          Replacement of problematic phrases with compliant
          alternatives (not removal of marketing messages).
        </LI>
        <LI>
          Addition of typical-experience disclosures in
          testimonial and before/after contexts.
        </LI>
        <LI>
          Substantiation-file development for any retained
          specific-outcome claims.
        </LI>
      </UL>

      <H2 id="implications">Implications for practices</H2>

      <OL>
        <LI>
          <Strong>The average practice site has 17 flaggable
          items.</Strong> If your site has never been audited,
          expect similar results.
        </LI>
        <LI>
          <Strong>FDA-approved/cleared misuse is nearly universal
          in med spa.</Strong> Running a single-afternoon audit on
          this specific issue closes a widespread pattern.
        </LI>
        <LI>
          <Strong>Testimonial framing is where FTC exposure
          concentrates.</Strong> Typical-experience gaps are the
          single most-common FTC-specific issue.
        </LI>
        <LI>
          <Strong>Regen medicine compliance posture is a visible
          marketplace differentiator.</Strong> The contrast between
          the 5% of regen sites with clean posture and the 95%
          with widespread issues is increasingly noticed by
          informed patients and referral partners.
        </LI>
        <LI>
          <Strong>Most issues are textual, not structural.</Strong>
          Correction is typically straightforward - practices
          that haven&rsquo;t done it are leaving easy gains on the
          table.
        </LI>
      </OL>

      <BQ>
        The specific problem patterns in healthcare practice
        marketing are consistent enough that a structured
        category-based review catches the overwhelming majority of
        issues. The rule set isn&rsquo;t mysterious; the practice
        discipline of applying it consistently is.
      </BQ>

      <H2 id="faqs">Frequently asked questions</H2>

      <H3>How was this sample selected?</H3>
      <P>
        Selected across specialty categories and practice sizes
        (solo-owner through multi-location groups). Not a random
        sample; specifically designed to reflect the observable
        marketplace of healthcare practice marketing.
      </P>

      <H3>What counts as a flaggable violation in this analysis?</H3>
      <P>
        Phrases or patterns matching Categories 1-5 as described in
        our FDA warning letter phrase analysis. Specific thresholds
        applied consistently across sites.
      </P>

      <H3>Do these findings translate to other practice types?</H3>
      <P>
        The categorical patterns (Categories 1-5) appear across
        healthcare generally. Specialty-specific patterns vary.
        The general prevalence findings likely translate to
        similar specialty mixes.
      </P>

      <H3>Is the 94% violation prevalence an overestimate?</H3>
      <P>
        It reflects systematic review against documented rule
        categories. Specific-site risk depends on additional
        factors (site traffic, specific claims, enforcement
        attention in the specialty). Prevalence of flaggable
        items isn&rsquo;t the same as enforcement likelihood.
      </P>

      <H3>How do I audit my own site against these findings?</H3>
      <P>
        Run your site through the 5-category analysis described
        in our FDA warning letter phrase post. Automated
        compliance software provides systematic coverage.
      </P>

      <H3>Will these patterns change over time?</H3>
      <P>
        Categories are remarkably stable; specific patterns within
        categories evolve. New patterns (AI-generated content,
        compounded-drug equivalency) emerge as new marketing
        practices and regulatory priorities develop.
      </P>

      <KeyTakeaways
        items={[
          "94% of healthcare practice sites reviewed had at least one Category 1-5 violation - near-universal exposure.",
          "FDA-approved/cleared misuse is the most prevalent single issue, particularly in med spa marketing.",
          "Unsubstantiated efficacy framing ('clinically proven') appears on 84% of reviewed sites.",
          "The 6% of clean-compliance sites share documented compliance programs, counsel relationships, and systematic review practices.",
          "Most violations are textual and correctable without structural changes - 2-8 hours of site-wide revision typically addresses the majority.",
        ]}
      />
    </>
  )
}
